Solubility and Physical Stability Enhancement of Loratadine by Preparation of Co-Amorphous Solid Dispersion with Chlorpheniramine and Polyvinylpyrrolidone

被引:4
|
作者
Suknuntha, Krit [1 ,2 ]
Khumpirapang, Nattakanwadee [3 ]
Tantishaiyakul, Vimon [1 ,2 ]
Okonogi, Siriporn [4 ,5 ]
机构
[1] Prince Songkla Univ, Fac Pharmaceut Sci, Drug Delivery Syst Excellence Ctr, Hat Yai 90110, Thailand
[2] Prince Songkla Univ, Fac Pharmaceut Sci, Dept Pharmaceut Chem, Hat Yai 90110, Thailand
[3] Naresuan Univ, Fac Pharmaceut Sci, Dept Pharmaceut Chem & Pharmacognosy, Phitsanulok 65000, Thailand
[4] Chiang Mai Univ, Fac Pharm, Dept Pharmaceut Sci, Chiang Mai 50200, Thailand
[5] Chiang Mai Univ, Fac Pharm, Ctr Excellence Pharmaceut Nanotechnol, Chiang Mai 50200, Thailand
关键词
loratadine; chlorpheniramine; polyvinylpyrrolidone; solubility enhancement; solid dispersion; amorphous; quench cooling; film casting; DRUG-POLYMER INTERACTIONS; WATER-SOLUBLE DRUGS; PHYSICOCHEMICAL CHARACTERIZATION; CRYSTALLIZATION INHIBITION; DISSOLUTION ENHANCEMENT; MELT EXTRUSION; AMINO-ACIDS; DELIVERY; BIOAVAILABILITY; ITRACONAZOLE;
D O I
10.3390/pharmaceutics15112558
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Loratadine (LRD), a non-sedating and slow-acting antihistamine, is often given in combination with short-onset chlorpheniramine maleate (CPM) to increase efficacy. However, LRD has poor water solubility resulting in low bioavailability. The aim of this study was to improve LRD solubility by preparing co-amorphous LRD-CPM. However, the obtained co-amorphous LRD-CPM recrystallized rapidly, and the solubility of LRD returned to a poor state again. Therefore, co-amorphous LRD-CPM solid dispersions using polyvinylpyrrolidone (PVP) as a carrier were prepared. The obtained solid dispersions were characterized using X-ray powder diffraction (XRPD), differential scanning calorimetry (DSC), and Fourier transform infrared spectroscopy (FT-IR). The solubility, dissolution, and mechanism of drug release from the LRD-CPM/PVP co-amorphous solid dispersions were studied and compared with those of intact LRD, LRD/PVP solid dispersions, and co-amorphous LRD-CPM mixtures. The results from XRPD and DSC confirmed the amorphous form of LRD in the co-amorphous solid dispersions. The FTIR results indicated that there was no intermolecular interaction between LRD, CPM, and PVP. In conclusion, the obtained LRD-CPM/PVP co-amorphous solid dispersions can successfully increase the water solubility and dissolution of LRD and extend the amorphous state of LRD without recrystallization.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Amino acids as co-amorphous stabilizers for poorly water soluble drugs - Part 1: Preparation, stability and dissolution enhancement
    Lobmann, Korbinian
    Grohganz, Holger
    Laitinen, Riikka
    Strachan, Clare
    Rades, Thomas
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2013, 85 (03) : 873 - 881
  • [32] How can we improve the physical stability of co-amorphous system containing flutamide and bicalutamide? The case of ternary amorphous solid dispersions
    Pacult, Justyna
    Rams-Baron, Marzena
    Chmiel, Krzysztof
    Jurkiewicz, Karolina
    Antosik, Agata
    Szafraniec, Joanna
    Kurek, Mateusz
    Jachowicz, Renata
    Paluch, Marian
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 136
  • [33] ACCELERATED STABILITY OF AN X-RAY AMORPHOUS FRUSEMIDE-POLYVINYLPYRROLIDONE SOLID DISPERSION
    DOHERTY, C
    YORK, P
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1989, 15 (12) : 1969 - 1987
  • [34] Characterization, stability and solubility of co-amorphous systems of glibenclamide and L-arginine at different pH
    Aragon-Aburto, Salma O.
    Mondragon-Vasquez, Karina
    Valerio-Alfaro, Gerardo
    Dominguez-Chavez, Jorge G.
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2022, 21 (07) : 1355 - 1364
  • [35] Influence of the cooling rate and the blend ratio on the physical stability of co-amorphous naproxen/indomethacin
    Beyer, Andreas
    Grohganz, Holger
    Lobmann, Korbinian
    Rades, Thomas
    Leopold, Claudia S.
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2016, 109 : 140 - 148
  • [36] Co-amorphous Drug Delivery Systems: a Review of Physical Stability, In Vitro and In Vivo Performance
    Qin Shi
    Yanan Wang
    Sakib M. Moinuddin
    Xiaodong Feng
    Fakhrul Ahsan
    AAPS PharmSciTech, 23
  • [37] Co-amorphous Drug Delivery Systems: a Review of Physical Stability, In Vitro and In Vivo Performance
    Shi, Qin
    Wang, Yanan
    Moinuddin, Sakib M.
    Feng, Xiaodong
    Ahsan, Fakhrul
    AAPS PHARMSCITECH, 2022, 23 (07)
  • [38] Co-Amorphous Drug Formulations in Numbers: Recent Advances in Co-Amorphous Drug Formulations with Focus on Co-Formability, Molar Ratio, Preparation Methods, Physical Stability, In Vitro and In Vivo Performance, and New Formulation Strategies
    Liu, Jingwen
    Grohganz, Holger
    Lobmann, Korbinian
    Rades, Thomas
    Hempel, Nele-Johanna
    PHARMACEUTICS, 2021, 13 (03)
  • [39] Selection of bionic Co-former improves the dissolution of Neohesperidin via Co-amorphous solid dispersion with Naringin
    Li, Jun
    Li, Min
    Jiang, Hua
    Chen, Lin
    Zhang, Ning
    Zhou, Yuan-qi
    Guo, Qing-xia
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2022, 181 : 159 - 172
  • [40] Tranilast-matrine co-amorphous system: Strong intermolecular interactions, improved solubility, and physiochemical stability
    Hu, Dandan
    Chen, Xin
    Li, Duanxiu
    Zhang, Hailu
    Duan, Yanwen
    Huang, Yong
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2023, 635